Sage Journals: Discover world-class research

Abstract

Standards in pupil dilation practices regarding the safety of human subjects are not present in vision research despite the potential for significant adverse effects. We developed two surveys to examine current practices around pupil dilation among vision researchers and individuals associated with oversight of human subjects research. While both groups note an absence of adverse events associated with pupil dilation, vision researcher practices differed with informed consent use and measures taken to minimize complications. For Institutional Review Boards, general risk assumption associated with dilation was not unanimous and there was a lack of specific guidance available to researchers for minimizing risk. These results uncover the need for standardized practices regarding pupil dilation in human subjects research.

Keywords

pupil dilation safety risk consent optometry ophthalmology

Get full access to this article

View all access options for this article.

References

Ah-Kee

E. Y.

Egong

Shafi

Lim

L. T.

Yim

J. L.

(2015). A review of drug-induced acute angle closure glaucoma for non-ophthalmologists. Qatar Medical Journal, 2015(1), 6. https://doi.org/10.5339/qmj.2015.6

Applebaum

Jaanus

S. D.

(1983). Use of diagnostic pharmaceutical agents and incidence of adverse effects. American Journal of Optometry and Physiological Optics, 60(5), 384–388. https://doi.org/10.1097/00006324-198305000-00007

Bausch & Lomb Incorporated. (2016). Cyclopentolate hydrochloride ophthalmic solution, USP 1%. https://www.bausch.com/Portals/77/-/m/BL/United%20States/Files/Package%20Inserts/Pharma/Rx-Generics/Cyclopentolate-Hydrochloride-Solution.pdf?ver=2016-09-13-101701-047

Bausch & Lomb Incorporated. (2019). Tropicamide ophthalmic solution, USP. https://www.bausch.com/Portals/77/-/m/BL/United%20States/Files/Package%20Inserts/Pharma/Rx-Generics/Tropicamide-package-insert.pdf?ver=2016-08-26-133847-873

Brooks

A. M.

West

R. H.

Gillies

W. E.

(1986). The risks of precipitating acute angle-closure glaucoma with the clinical use of mydriatic agents. The Medical Journal of Australia, 145(1), 34–36.

Camarasa

J. G.

Pla

(1996). Allergic contact dermatitis from cyclopentolate. Contact Dermatitis, 35(6), 368–369. https://doi.org/10.1111/j.1600-0536.1996.tb02424.x

Costa

A. X. D.

M. C.

de Freitas

Cristovam

P. C.

LaMonica

L. C.

dos Santos

V. R.

Gomes

J. A. P.

(2020). Microbial cross-contamination in multidose eyedrops: The impact of instillation angle and bottle geometry. Translational Vision Science & Technology, 9(7), 7. https://doi.org/10.1167/tvst.9.7.7

Coulter

R. A.

Bartlett

J. D.

Fiscella

R. G.

(2008). Pharmacotherapy of the ophthalmic patient. In Fiscella

R. G.

Holdeman

N. R.

Prokopich

C. L.

(Eds.), Clinical ocular pharmacology (5th ed., pp. 3–15). Butterworth-Heinemann.

Dabasia

P. L.

Edgar

D. F.

Murdoch

I. E.

Lawrenson

J. G.

(2015). Noncontact screening methods for the detection of narrow anterior chamber angles. Investigative Ophthalmology & Visual Science, 56(6), 3929–3935. https://doi.org/10.1167/iovs.15-16727

10.

Department of Health & Human Services. (2018). General instructions for NIH and other PHS agencies, Version E. https://grants.nih.gov/grants/how-to-apply-application-guide/forms-e/general-forms-e.pdf

11.

Farkouh

Frigo

Czejka

(2016). Systemic side effects of eye drops: A pharmacokinetic perspective. Clinical Ophthalmology, 10, 2433–2441. https://doi.org/10.2147/OPTH.S118409

12.

Fraunfelder

F. T.

Meyer

S. M.

(1984). The national registry of drug-induced ocular side effects. Australian Journal of Ophthalmology, 12(2), 129–131.

13.

Haroun-Díaz

Ruíz-García

De Luxán de la Lastra

Pastor-Vargas

De las Heras

Sastre Domínguez

Cuesta-Herranz

(2014). Contact dermatitis to both tropicamide and phenylephrine eye drops. Dermatitis, 25(3), 149–150. https://doi.org/10.1097/DER.0000000000000043

14.

Huang

Friedman

D. S.

Zheng

Foster

P. J.

(2007). Slit lamp-simulated oblique flashlight test in the detection of narrow angles in Chinese eyes: The Liwan eye study. Investigative Ophthalmology & Visual Science, 48(12), 5459–5463. https://doi.org/10.1167/iovs.07-0670

15.

Joint Commission on Allied Health Personnel in Ophthalmology. (2013). Best practices* procedure for instillation of eye drops. http://documents.jcahpo.org/EyeLights/0413/EyeDrop_Ointment_Checklist.pdf

16.

Kessels

R. P.

(2003). Patients’ memory for medical information. Journal of the Royal Society of Medicine, 96(5), 219–222. https://doi.org/10.1258/jrsm.96.5.219

17.

Labetoulle

Frau

Le Jeunne

(2005). Systemic adverse effects of topical ocular treatments. La Presse Medicale, 34(8), 589–595. https://doi.org/10.1016/s0755-4982(05)83987-9

18.

Lachkar

Bouassida

(2007). Drug-induced acute angle closure glaucoma. Current Opinion in Ophthalmology, 18(2), 129–133. https://doi.org/10.1097/ICU.0b013e32808738d5

19.

Lai

Y. K.

(1989). Adverse effect of intraoperative phenylephrine 10%: Case report. British Journal of Ophthalmology, 73(6), 468–469. https://doi.org/10.1136/bjo.73.6.468

20.

Lai

J. S.

Gangwani

R. A.

(2012). Medication-induced acute angle closure attack. Hong Kong Medical Journal, 18(2), 139–145.

21.

Lavanya

Foster

P. J.

Sakata

L. M.

Friedman

D. S.

Kashiwagi

Wong

T. Y.

Aung

H. T.

Alfred

Gao

A. G.

Seah

S. K.

Aung

(2008). Screening for narrow angles in the Singapore population: Evaluation of new noncontact screening methods. Ophthalmology, 115(10), 1720–1727. https://doi.org/10.1016/j.ophtha.2008.03.015

22.

Laws

M. B.

Lee

Taubin

Rogers

W. H.

Wilson

I. B.

(2018). Factors associated with patient recall of key information in ambulatory specialty care visits: Results of an innovative methodology. PLoS One, 13(2), e0191940. https://doi.org/10.1371/journal.pone.0191940

23.

Lee

(2007). Hand washing. Ophthalmology, 114(6), 1229–1230. https://doi.org/10.1016/j.ophtha.2007.03.037

24.

Madsen

J. T.

Andersen

K. E.

(2015). Phenylephrine is a frequent cause of periorbital allergic contact dermatitis. Contact Dermatitis, 73(1), 64–65. https://doi.org/10.1111/cod.12394

25.

Mapstone

(1977). Dilating dangerous pupils. British Journal of Ophthalmology, 61(8), 517–524. https://doi.org/10.1136/bjo.61.8.517

26.

Meyer

S. M.

Fraunfelder

F. T.

(1980). Phenylephrine hydrochloride. Ophthalmology, 87(11), 1177–1180. https://doi.org/10.1016/s0161-6420(80)35108-7

27.

Mirshahi

Kohnen

(2003). Acute psychotic reaction caused by topical cyclopentolate use for cycloplegic refraction before refractive surgery: Case report and review of the literature. Journal of Cataract and Refractive Surgery, 29(5), 1026–1030. https://doi.org/10.1016/s0886-3350(02)01651-6

28.

Müller

Jensen

B. P.

Bachmann

L. M.

Wong

Wells

A. P.

(2020). New technique to reduce systemic side effects of timolol eye drops: The tissue press method-cross-over clinical trial. Clinical & Experimental Ophthalmology, 48(1), 24–30. https://doi.org/10.1111/ceo.13642

29.

Nevitt

M. P.

(2013). Clinical review: NDA 203510. https://www.fda.gov/media/86163/download#:~:text=Systemic%20adverse%20reactions%20to%20phenylephrine,arrhythmia%20and%20fatal%20subarachnoid%20hemorrhage

30.

Office for Human Research Protections. (2018). Protection of human subjects, 45 CFR 46. https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html

31.

Pandit

R. J.

Taylor

(2000). Mydriasis and glaucoma: Exploding the myth. A systematic review. Diabetic Medicine, 17(10), 693–699. https://doi.org/10.1046/j.1464-5491.2000.00368.x

32.

Paragon BioTeck Inc. (2014). Phenylephrine hydrochloride ophthalmic solution, USP 2.5% and 10%. https://paragonbioteck.com/wp-content/uploads/phenyl-insert.pdf

33.

Park

S. B.

Sung

K. R.

Kang

S. Y.

J. W.

Lee

K. S.

Kook

M. S.

(2011). Assessment of narrow angles by gonioscopy, Van Herick method, and anterior segment optical coherence tomography. Japanese Journal of Ophthalmology, 55(4), 343–350. https://doi.org/10.1007/s10384-011-0036-0

34.

Portello

J. K.

Krumholz

D. M.

(2008). Dilation of the pupil. In Fiscella

R. G.

Holdeman

N. R.

Prokopich

C. L.

(Eds.), Clinical ocular pharmacology (5th ed., pp. 329–341). Butterworth-Heinemann.

35.

Prum

B. E.

Jr. Herndon

L. W.

Jr. Moroi

S. E.

Mansberger

S. L.

Stein

J. D.

Lim

M. C.

Rosenberg

L. F.

Gedde

S. J.

Williams

R. D.

(2016). Primary angle closure preferred practice pattern (®) guidelines. Ophthalmology, 123(1), P1–P40. https://doi.org/10.1016/j.ophtha.2015.10.049

36.

Rajeev

Gupta

Adhikari

K. M.

Yadav

A. K.

Sathyamoorthy

(2010). Neurotoxic effects of topical cyclopentolate. Medical Journal Armed Forces India, 66(3), 288–289. https://doi.org/10.1016/S0377-1237(10)80069-3

37.

Rushing

(2007). Administering eyedrops. Nursing, 37(5), 18. https://doi.org/10.1097/01.NURSE.0000268750.66057.92

38.

Shur

Checkley

(1982). Pupil studies in depressed patients: An investigation of the mechanism of action of desipramine. The British Journal of Psychiatry, 140(2), 181–184. https://doi.org/10.1192/bjp.140.2.181

39.

Smith

S. D.

Singh

Lin

S. C.

Chen

P. P.

Chen

T. C.

Francis

B. A.

Jampel

H. D.

(2013). Evaluation of the anterior chamber angle in glaucoma: A report by the American academy of ophthalmology. Ophthalmology, 120(10), 1985–1997. https://doi.org/10.1016/j.ophtha.2013.05.034

40.

Stavert

McGuinness

M. B.

Harper

C. A.

Guymer

R. H.

Finger

R. P.

(2015). Cardiovascular adverse effects of phenylephrine eyedrops: A systematic review and meta-analysis. JAMA Ophthalmology, 133(6), 647–652. https://doi.org/10.1001/jamaophthalmol.2015.0325

41.

van Minderhout

H. M.

Joosse

M. V.

Grootendorst

D. C.

Schalij-Delfos

N. E

. (2015). Adverse reactions following routine anticholinergic eye drops in a paediatric population: An observational cohort study. BMJ Open, 5(12), e008798.

42.

Vuori

M. L.

Kaila

Iisalo

Saari

K. M.

(1994). Systemic absorption and anticholinergic activity of topically applied tropicamide. Journal of Ocular Pharmacology, 10(2), 431–437. https://doi.org/10.1089/jop.1994.10.431

43.

Wakayama

Nishina

Miki

Utsumi

Sugasawa

Hayashi

Sato

Kimura

Fujikado

(2018). Incidence of side effects of topical atropine sulfate and cyclopentolate hydrochloride for cycloplegia in Japanese children: A multicenter study. Japanese Journal of Ophthalmology, 62(5), 531–536. https://doi.org/10.1007/s10384-018-0612-7

44.

Wolfs

R. C.

Grobbee

D. E.

Hofman

de Jong

P. T.

(1997). Risk of acute angle-closure glaucoma after diagnostic mydriasis in nonselected subjects: The Rotterdam study. Investigative Ophthalmology & Visual Science, 38(12), 2683–2687.

45.

World Health Organization. (2010). 2 Best practices in phlebotomy. https://www.ncbi.nlm.nih.gov/books/NBK138665/

46.

Yolton

D. P.

Kandel

J. S.

Yolton

R. L.

(1980). Diagnostic pharmaceutical agents: Side effects encountered in a study of 15,000 applications. Journal of the American Optometric Association, 51(2), 113–118.

47.

Yoon

J. Y.

Hong

Y. J.

Kim

C. Y.

(2003). Cataract surgery in patients with acute primary angle-closure glaucoma. Korean Journal of Ophthalmology, 17(2), 122–126. https://doi.org/10.3341/kjo.2003.17.2.122

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.75 MB

1.31 MB

0.06 MB

Characterizing Current Attitudes and Practices for Human Subject Safety in Studies Involving Pupil Dilation

Abstract

Keywords

Get full access to this article

References

Supplementary Material